Fukugasako Sanae, Ito Shinichi, Ikemoto Yoshimi
Department of Dental Anesthesiology, Faculty of Dental Science, Kyushu University, Fukuoka 812-8582, Japan.
Br J Pharmacol. 2003 May;139(2):381-7. doi: 10.1038/sj.bjp.0705248.
1 Mechanisms of methyl p-hydroxybenzoate (methyl paraben) action in allergic reactions were investigated by measuring the intracellular Ca(2+) concentration (Ca(2+)) and histamine release in rat peritoneal mast cells (RPMCs). 2 In the presence or absence of extracellular Ca(2+), methyl paraben (0.1-10 mM) increased Ca(2+), in a concentration-dependent manner. Under both the conditions, methyl paraben alone did not evoke histamine release. 3 In RPMCs pretreated with a protein kinase C (PKC) activator (phorbol 12-myristate 13-acetate (PMA) 3 and 10 nM), methyl paraben (0.3-3 mM) induced histamine release. However, a high concentration (10 mM) of the agent did not increase the histamine release. 4 U73122 (0.1 and 0.5 micro M), an inhibitor of phospholipase C (PLC), significantly inhibited the methyl paraben-induced histamine release in PMA-pretreated RPMCs. U73343 (0.5 micro M), an inactive analogue of U73122, did not inhibit the histamine release caused by methyl paraben. 5 In Ca(2+)-free solution, PLC inhibitors (U73122 0.1 and 0.5 micro M, D609 1-10 micro M) inhibited the methyl paraben-induced increase in Ca(2+), whereas U73343 (0.5 micro M) did not. 6 Xestospongin C (2-20 micro M) and 2 aminoethoxydiphenyl borate (30 and 100 micro M), blockers of the inositol 1,4,5-trisphosphate (IP(3)) receptor, inhibited the methyl paraben-induced increase in Ca(2+) in Ca(2+)-free solution. 7 In conclusion, methyl paraben causes an increase in Ca(2+), which may be due to release of Ca(2+) from storage sites by IP(3) via activation of PLC in RPMCs. In addition, methyl paraben possibly has some inhibitory effects on histamine release via unknown mechanisms.
1 通过测量大鼠腹膜肥大细胞(RPMCs)中的细胞内钙离子浓度([Ca(2+)]i)和组胺释放,研究了对羟基苯甲酸甲酯(尼泊金甲酯)在过敏反应中的作用机制。2 在存在或不存在细胞外钙离子的情况下,对羟基苯甲酸甲酯(0.1 - 10 mM)以浓度依赖性方式增加[Ca(2+)]i。在这两种条件下,单独的对羟基苯甲酸甲酯均未引起组胺释放。3 在预先用蛋白激酶C(PKC)激活剂(佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯(PMA)3和10 nM)处理的RPMCs中,对羟基苯甲酸甲酯(0.3 - 3 mM)诱导组胺释放。然而,高浓度(10 mM)的该试剂并未增加组胺释放。4 磷脂酶C(PLC)抑制剂U73122(0.1和0.5 μM)显著抑制了PMA预处理的RPMCs中对羟基苯甲酸甲酯诱导的组胺释放。U73122的无活性类似物U73343(0.5 μM)未抑制对羟基苯甲酸甲酯引起的组胺释放。5 在无钙溶液中,PLC抑制剂(U73122 0.1和0.5 μM,D609 1 - 10 μM)抑制了对羟基苯甲酸甲酯诱导的[Ca(2+)]i增加,而U73343(0.5 μM)则没有。6 肌醇1,4,5 - 三磷酸(IP(3))受体阻滞剂西司他汀C(2 - 20 μM)和2 - 氨基乙氧基二苯硼酸(30和100 μM)在无钙溶液中抑制了对羟基苯甲酸甲酯诱导的[Ca(2+)]i增加。7 总之,对羟基苯甲酸甲酯导致[Ca(2+)]i增加,这可能是由于IP(3)通过激活RPMCs中的PLC从储存位点释放钙离子所致。此外,对羟基苯甲酸甲酯可能通过未知机制对组胺释放有一些抑制作用。